Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuragen vs Heparin for CRBSI Prevention in Dialysis Catheters
NCT00628680Phase 3Unknown
- Sponsor
- Ash Access Technology, Inc.
- Start
- Jul 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of Zuragen in catheter-related bloodstream infection (CRBSI), sponsored by Ash Access Technology, Inc.. Status: unknown.
02
Drugs
Zuragen
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT00628680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628680.